How do healthcare providers, payers and governments tackle the challenges of specialty treatments ? How do you determine the impact on not only costs but clinical outcomes? Whether it’s specialty treatments or specialty drugs. How is the industry planning to address the flood of expensive personalized treatments and medications coming in the future? Will the most expensive treatments and cures only be available to the wealthy? Will patients travel to seek out the most cutting edge and expensive therapy or will they travel to find affordable options with high clinical outcomes?